Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1P1I vs 2P2I US-SCBPB for Upper Extremity Surgery
NCT02505633Completed
- Sponsor
- Gachon University Gil Medical Center
- Start
- Jul 2015
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine and epinephrine, sponsored by Gachon University Gil Medical Center. Primary endpoint: Rate of complete sensory blockade of all 4 nerves at 30 months. Started Jul 2015; status: completed.
02
Drugs
lidocaineepinephrine
Beyond the preview
Go deeper on NCT02505633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505633.